Regency Capital Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Regency Capital Management's LLY Position: Q4 2021 in Review
Regency Capital Management sold out of Eli Lilly (LLY) in Q4 2021, closing a stake of 170 shares — an estimated $39K sold.
Regency Capital Management first reported a position in LLY in Q1 2021 and held it in 2 quarters. The position peaked at $282K in Q1 2021. 2,304 funds tracked by Wall St. Rank hold LLY as of Q4 2021.
- Regency Capital Management reported no remaining Eli Lilly position as of Q4 2021 after selling out during the quarter.
- Regency Capital Management sold 170 Eli Lilly shares in Q4 2021, an estimated $39K.
- Regency Capital Management first reported a position in Eli Lilly in Q1 2021 and held it in 2 quarters.
- Regency Capital Management's Eli Lilly position peaked at $282K in Q1 2021.
- 2,304 funds tracked by Wall St. Rank held Eli Lilly as of Q4 2021.
Based on Regency Capital Management's 13F filing for Q4 2021, filed 3 Feb 2022.